Site Care is Critical for Glycemic Control

 Scar tissue and lipohypertrophy (LH) at injection sites are a major barrier to insulin absorption

 

Thousands of Micro-traumas

Scarring and fatty tissue (LH) can develop from the micro-trauma of multiple daily injections (MDIs), or on-going use of wearables such as insulin pumps and continuous glucose monitors (CGMs). 

Over weeks, months and years of wearables and/or injections,  you're subjecting your skin to thousands of micro-traumas. These traumas add up - leaving you with damaged tissue under the skin.

Scar tissue does not absorp insulin well. This can cause daily management issues and eventually serious diabetes complications.

Prevent and Protect

The embrace® patch provides active compression to help protect sites

embrace® actively shrinks to compress the site, reducing the body’s inflammatory response. Compression limits fibrosis and the immune response linked to scarring and LH.

embrace® is the only 510(k) cleared medical device proven in multiple clinical trials* to PREVENT scarring under the surface of the skin.

embrace® can be used in combination with your site rotation patterns to ensure lasting site health.

Compression controls healing environment

Our Dual Action Technology is One of a Kind

 

 

Contracts

When applied, the embrace® patch shrinks and delivers an active, compressive force to the treatment site.

Compresses

embrace's continuous compression penetrates deep into the subcutaneous tissue to:

✓  Minimize the inflammatory response from micro-injuries

✓  Restrict fibroblast production and collagen deposits to prevent the formation of scar tissue

✓  Repair exhausted sites by remodeling damaged tissue

 


 

embrace is Easy to Use, Discreet, and Comfortable to Wear

  • Simple 3-step application
  • No daily steps, hassle-free treatment 
  • Convenient, comfortable 10-day wear time
  • Lightweight and barely visible while wearing
  • Water-resistant, no need to remove during everyday activities, such as showering, exercise etc
 

Prevent

Contracts and compresses to treat the root cause of scarring

 

Protect

Continuous compression controls the wound healing process

 

Repair

Recover preferred injection sites

 

Getting Started With embrace is Simple

Align

Protect your site

Apply

Just set and go

Wear

Wear for approx. 10 days

Amplify the Benefits of Site Rotation by Adding embrace

Your site health plays a critical role in your diabetes management plan. The embrace patch can be used in combination with site rotation patterns to minimize the damage from insertion of CGMs, pump sets, and insulin injections. 

Wound healing is a natural and continuous process. Understanding that process allowed us to create a powerful compliment to improve the way your sites heal.

Preserving healthy skin is clinically proven to improve long term diabetes outcomes.

 

Rotation Guides

Below you’ll find rotation guides created to help teach you how to add embrace into your diabetes care routine, based on clinical rotation guidelines. You may want to consult with your physician when modifying your treatment routine.

Download

stack of papers Tips for Patients Using Insulin Pumps

Experts agree with the following steps*:

  • Choose a part of the body
  • Divide into 4 areas
  • Use one area every 7-10 days depending on your pump set type
  • Always use a new site
  • Avoid using a single site more than once every 4 weeks
  • Follow your health care professional's recommendations for site rotation

Use for diabetes-related injection-induced scarring

Scarring from on-going use of wearables can significantly impact glycemic control

  • GREATER glycemic variability - up to 7 times higher*
  • INCREASED use of insulin - up to 35% more†
  • HIGHER A1c level - up to 0.55 higher*
diagram of device with parts labeled

STEP 1: Apply

Holding embrace® on its outer edges, use the Peel Tabs to peel off the clear protective liner that covers the adhesive patch.

DO NOT touch the adhesive patch with your fingers.

Gently bow the Applicator with both hands to remove any creases and pockets

Position embrace® over the injection/scarred area so that the Applicator is parallel to the length of the area and faces away from your skin.

PRESS AND HOLD embrace® against the skin for 60 seconds. Make sure to press firmly on the edges and corners.

STEP 2: Release

Use one hand to hold embrace® in place. Use the other hand to press firmly across the entire surface area of the Applicator to ensure the patch is adhered well to the skin.

Holding embrace® against your skin with one hand, use your other hand to pull one Release Tab to the side along with the edge of the Applicator.

Repeat this step with the other Release Tab. The Applicator will completely detach, leaving the patch adhered to the skin.

Smooth out any uneven areas, flatten any air pockets, and secure and raised corners or edges.

Example for Omnipod site rotation with embrace medium

Day 1 - 9

Area = 3 pod sites
Insert 3 pods aligned in area of choice

Day 10

After removing the third pod, immediately apply embrace over injured sited to PROTECT from scarring. Wear 9 days while pumping in next area

Day 19

Rotate pods to a new area and repeat treatment with embrace at previously used site

Day 28

Continue rotation pattern with each new area used

Example for 3 Day pump infusion set site rotation with embrace medium

Day 1

Area = 3 pod sites
Insert 3 pods aligned in area of choice

Day 10

After removing third pod, immediately apply embrace over injured sites to PROTECT from scarring. Wear 9 days while pumping in next area

Day 20

Rotate pods to new area and repeat treatment with embrace at previously used site

Day 30

Continue rotation pattern with each new area used

Example for 7 Day pump infusion set site rotation with embrace small

Week 1

Insert pumpset in area of choice

Week 2

After removing, immediately apply embrace over injured site to PROTECT from scarring. Wear 7 days while pumping in next area

Week 3

Rotate pumpset to new area and repeat treatment with embrace at previously used site

Week 4

Continue rotation pattern with each new area used

Frid, A. H., Hirsch, L. J., Menchior, A. R., Morel, D. R. & Strauss, K. W. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional. Mayo Clin Proc 91, 1224-30, doi:10.1016/j.mayocp.2016.06.012 (2016).

Blanco, M., Hernández, M. T., Strauss, K. W., Amaya, M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metab. 2013 Oct; 39(5) 445–53. doi:10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22. PMID: 23886784.

Frid, A. H., Kreugel G., Grassi G., et.al. New insulin delivery recommendations. Mayo Clin Proc 2016-91(9) 1231-55

We're here to support your use of embrace® to make sure you experience the best possible results. Contact us for questions or additional information.

1-855-722-7879
Mon-Fri 8AM-4:30PM EST
support@neodynebio.com
www.EmbraceDiabetesCare.com

EMBRACE is a registered trademark of Neodyne Biosciences, Inc. All other trademarks are the property of their respective owners. © Neodyne Biosciences, Inc. All Rights Reserved.

Download

stack of papers Tips for Patients Injecting Daily

Experts agree with the following steps*:

  • Choose a part of the body
  • Divide into 4 areas
  • Use one area every 7-10 days depending on your CGM
  • Always use a new site
  • Avoid using a single site more than once every 4 weeks
  • Follow your health care professional's recommendations for site rotation

Use for diabetes-related injection-induced scarring

Scarring from on-going use of wearables can significantly impact glycemic control

  • GREATER glycemic variability - up to 7 times higher*
  • INCREASED use of insulin - up to 35% more†
  • HIGHER A1c level - up to 0.55 higher*
diagram of device with parts labeled

STEP 1: Apply

Holding embrace® on its outer edges, use the Peel Tabs to peel off the clear protective liner that covers the adhesive patch.

DO NOT touch the adhesive patch with your fingers.

Gently bow the Applicator with both hands to remove any creases and pockets

Position embrace® over the injection/scarred area so that the Applicator is parallel to the length of the area and faces away from your skin.

PRESS AND HOLD embrace® against the skin for 60 seconds. Make sure to press firmly on the edges and corners.

STEP 2: Release

Use one hand to hold embrace® in place. Use the other hand to press firmly across the entire surface area of the Applicator to ensure the patch is adhered well to the skin.

Holding embrace® against your skin with one hand, use your other hand to pull one Release Tab to the side along with the edge of the Applicator.

Repeat this step with the other Release Tab. The Applicator will completely detach, leaving the patch adhered to the skin.

Smooth out any uneven areas, flatten any air pockets, and secure and raised corners or edges.

Example for site rotation while injecting daily using embrace large

Day 1 - 10

Inject per your physician's recommendations in area of choice

Day 11

Immediately apply embrace over injured injection site to PROTECT from scarring. Wear 10 days while injecting new area

Day 22

Repeat treatment with embrace at previously used site and rotate injections to next area

Day 33

Continue rotation pattern with each new area used

Frid, A. H., Hirsch, L. J., Menchior, A. R., Morel, D. R. & Strauss, K. W. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional. Mayo Clin Proc 91, 1224-30, doi:10.1016/j.mayocp.2016.06.012 (2016).

Blanco, M., Hernández, M. T., Strauss, K. W., Amaya, M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metab. 2013 Oct; 39(5) 445–53. doi:10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22. PMID: 23886784.

Frid, A. H., Kreugel G., Grassi G., et.al. New insulin delivery recommendations. Mayo Clin Proc 2016-91(9) 1231-55

We're here to support your use of embrace® to make sure you experience the best possible results. Contact us for questions or additional information.

1-855-722-7879
Mon-Fri 8AM-4:30PM EST
support@neodynebio.com
www.EmbraceDiabetesCare.com

EMBRACE is a registered trademark of Neodyne Biosciences, Inc. All other trademarks are the property of their respective owners. © Neodyne Biosciences, Inc. All Rights Reserved.

Download

stack of papers Tips for Patients Using CGMs

Experts agree with the following steps*:

  • Choose a part of the body
  • Divide into 4 areas
  • Use one area every 7-10 days depending on your CGM
  • Always use a new site
  • Avoid using a single site more than once every 4 weeks
  • Follow your health care professional's recommendations for site rotation

Use for diabetes-related injection-induced scarring

Scarring from on-going use of wearables can significantly impact glycemic control

  • GREATER glycemic variability - up to 7 times higher*
  • INCREASED use of insulin - up to 35% more†
  • HIGHER A1c level - up to 0.55 higher*
diagram of device with parts labeled

STEP 1: Apply

Holding embrace® on its outer edges, use the Peel Tabs to peel off the clear protective liner that covers the adhesive patch.

DO NOT touch the adhesive patch with your fingers.

Gently bow the Applicator with both hands to remove any creases and pockets

Position embrace® over the injection/scarred area so that the Applicator is parallel to the length of the area and faces away from your skin.

PRESS AND HOLD embrace® against the skin for 60 seconds. Make sure to press firmly on the edges and corners.

STEP 2: Release

Use one hand to hold embrace® in place. Use the other hand to press firmly across the entire surface area of the Applicator to ensure the patch is adhered well to the skin.

Holding embrace® against your skin with one hand, use your other hand to pull one Release Tab to the side along with the edge of the Applicator.

Repeat this step with the other Release Tab. The Applicator will completely detach, leaving the patch adhered to the skin.

Smooth out any uneven areas, flatten any air pockets, and secure and raised corners or edges.

Example for 7 Day CGM Site Rotation with embrace small

Week 1

Insert CGM in area of choice. Wear 7 days and then rotate to next area

Week 2

After removing, immediately apply embrace over injured site to PROTECT from scarring. Wear 7 days while wearing CGM in next area

Week 3

Rotate CGM to new area and repeat treatment with embrace at previously used site

Week 4

Repeat rotation pattern with each new area used

Example for 14 Day CGM Site Rotation with embrace small

Week 1 & 2

Insert CGM in area of choice. Wear 14 days and then rotate to next area

Week 3 & 4

After removing, immediately apply embrace over injured site to PROTECT from scarring. Wear 10-14 days while wearing CGM in next area. Repeat rotation pattern with each new area used

Frid, A. H., Hirsch, L. J., Menchior, A. R., Morel, D. R. & Strauss, K. W. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional. Mayo Clin Proc 91, 1224-30, doi:10.1016/j.mayocp.2016.06.012 (2016).

Blanco, M., Hernández, M. T., Strauss, K. W., Amaya, M. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes. Diabetes & Metab. 2013 Oct; 39(5) 445–53. doi:10.1016/j.diabet.2013.05.006. Epub 2013 Jul 22. PMID: 23886784.

Frid, A. H., Kreugel G., Grassi G., et.al. New insulin delivery recommendations. Mayo Clin Proc 2016-91(9) 1231-55

We're here to support your use of embrace® to make sure you experience the best possible results. Contact us for questions or additional information.

1-855-722-7879
Mon-Fri 8AM-4:30PM EST
support@neodynebio.com
www.EmbraceDiabetesCare.com

EMBRACE is a registered trademark of Neodyne Biosciences, Inc. All other trademarks are the property of their respective owners. © Neodyne Biosciences, Inc. All Rights Reserved.

Protect Your Sites With embrace

 

 

"I am excited for the possiblity of embrace to use for prevention of LH because until now the only treatment for LH was to rotate their insulin sites!"

- Nancy Bristow, 
RN,CDCES

 

 

"embrace will change the treatement of lipohypertrophy like continuous glucose monitoring changed how people with diabetes check their blood sugar"

- David K Miller,
RN, BSN, MS Ed, CDCES, LDE

 

 

"Being able to provide a simple patch solution to resolve fibrotic scarring versus multiple topical applications a day is an easy decision to make"

- Christina DiLoreto,
RD, LD, CDCES